• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

Compound CAS No. 1009335-36-7: (3R,5R)-5-(Hydroxymethyl)pyrrolidin-3-ol; Hydrochloride

The compound with CAS No. 1009335-36-7, commonly referred to as (3R,5R)-5-(hydroxymethyl)pyrrolidin-3-ol; hydrochloride, is a biologically active molecule that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the class of pyrrolidine derivatives, which are known for their diverse applications in drug discovery and development. The (3R,5R) stereochemistry plays a crucial role in determining its physical and chemical properties, as well as its biological activity.

Recent studies have highlighted the potential of (3R,5R)-5-(hydroxymethyl)pyrrolidin-3-ol; hydrochloride in modulating cellular signaling pathways. Researchers have demonstrated that this compound exhibits selective binding to specific receptors, making it a promising candidate for therapeutic interventions in various diseases. For instance, its ability to inhibit certain kinases has been explored in the context of cancer treatment, where targeted therapies are highly sought after.

The synthesis of (3R,5R)-5-(hydroxymethyl)pyrrolidin-3-ol; hydrochloride involves a multi-step process that requires precise control over stereochemistry. The use of chiral catalysts and enantioselective reactions has enabled the efficient production of this compound with high optical purity. This is particularly important for its application in drug development, where stereochemistry can significantly influence pharmacokinetics and efficacy.

In terms of physical properties, (3R,5R)-5-(hydroxymethyl)pyrrolidin-3-ol; hydrochloride is characterized by its melting point and solubility profiles. These properties are critical for determining its suitability in various dosage forms, such as tablets or injections. Recent advancements in analytical techniques have allowed for more accurate characterization of this compound, ensuring its quality and consistency for pharmaceutical applications.

The biological activity of (3R,5R)-5-(hydroxymethyl)pyrrolidin-3-ol; hydrochloride has been extensively studied using in vitro and in vivo models. Preclinical data suggest that it exhibits potent anti-inflammatory and antioxidant effects, which could be beneficial in treating chronic diseases such as neurodegenerative disorders. Furthermore, its ability to cross the blood-brain barrier has been a focal point of recent research, highlighting its potential for central nervous system-related therapies.

From a regulatory standpoint, the development of (3R,5R)-5-(hydroxymethyl)pyrrolidin-3-ol; hydrochloride as a pharmaceutical agent requires stringent compliance with international standards. Regulatory agencies emphasize the importance of thorough toxicological evaluations and bioavailability studies to ensure patient safety and efficacy. Recent regulatory updates have also emphasized the need for sustainable manufacturing practices to minimize environmental impact.

In conclusion, (3R,5R)-5-(hydroxymethyl)pyrrolidin-3-ol; hydrochloride represents a significant advancement in the field of medicinal chemistry. Its unique chemical structure and biological activity make it a valuable tool for addressing unmet medical needs. As research continues to uncover new insights into its mechanisms of action and therapeutic potential, this compound is poised to play a pivotal role in the development of innovative treatments across various therapeutic areas.

• 921202-88-2(3-Pyrrolidinol, 2-ethyl-, (2S,3R)-)
• 825644-11-9(2-Pyrrolidinemethanol, 4-hydroxy-, (2R,4S)-)
• 529484-13-7(3,4-PYRROLIDINEDIOL, 2-METHYL-, HYDROCHLORIDE, (2S,3S,4R)-)
• 946434-18-0(8-Azabicyclo[3.2.1]octan-6-ol)
• 1788041-50-8(endo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride)
• 1788054-75-0(endo-7-azabicyclo[2.2.1]heptan-2-ol;hydrochloride)
• 478922-47-3((3R,5S)-5-(Hydroxymethyl)pyrrolidin-3-ol Hydrochloride)
• 98900-30-2((2R,3S)-2-(hydroxymethyl)pyrrolidin-3-ol;hydrochloride)
• 1788054-92-1(exo-8-azabicyclo[3.2.1]octan-6-ol;hydrochloride)
• 104587-51-1((3R,5S)-5-(hydroxymethyl)pyrrolidin-3-ol)